I. Castellví

The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements

Anna‐Maria Hoffmann‐Vold, Toby M. Maher, E. Philpot et al. · The Lancet Rheumatology · 2020 · 300 citations

Medicine, Clinical Sciences, Internal Medicine +16

EULAR recommendations for the treatment of systemic sclerosis: 2023 update

Francesco Del Galdo, Alain Lescoat, Philip G. Conaghan et al. · Annals of the Rheumatic Diseases · 2024 · 215 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +12

Immunochip Analysis Identifies Multiple Susceptibility Loci for Systemic Sclerosis

Maureen D. Mayes, Lara Bossini‐Castillo, Olga Y. Gorlova et al. · The American Journal of Human Genetics · 2014 · 208 citations · Full text

Life Sciences, Immunology, Neurology +12

Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study

Muriel Elhaï, Marouane Boubaya, Oliver Distler et al. · Annals of the Rheumatic Diseases · 2019 · 188 citations · Full text

Medicine, Immunology, Pharmacotherapy +14

Recommendations for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated rapidly progressive interstitial lung disease

Fredeswinda Romero-Bueno, P. Díaz del Campo, Ernesto Trallero‐Araguás et al. · Seminars in Arthritis and Rheumatism · 2020 · 182 citations · Full text

Medicine, Dermatology, Oncology +14